CASR and type 2 diabetes mellitus: Among the 106 patients included, 45 were women (42.5%), 38 had diabetes (type 2 diabetes in all cases) (35.8%), 61 had been prescribed CaSR agonist (57.5%), and 97 had been prescribed VDRA (91.5%).